Skip to main content

Research & Evidence

GLP-1 Side Effects: When to Call or Seek Urgent Help

By Allura Health & WellnessPublished Updated 3 min read
Allura editorial illustration

For your understanding.

This article is for general education and is not medical advice. It does not replace an individual assessment or guidance from a qualified healthcare professional.

Nausea, constipation, diarrhea and vomiting can occur with GLP-1-based medicines. A symptom being common does not mean it should be ignored when it is severe, persistent or prevents you from eating and drinking.

Semaglutide and tirzepatide have product-specific warnings. Use the medication guide supplied with your prescription and the plan from your treating clinician. This overview helps organize questions; it cannot determine the cause or urgency of an individual symptom.

Emergencies: get help immediately

Call 911 or seek emergency care for trouble breathing, swelling that affects the mouth or throat, collapse, a seizure or inability to awaken. Do not wait for a reply to a routine clinic message. These are emergency symptoms regardless of whether the medicine caused them.

The semaglutide injection information and tirzepatide information describe serious allergic reactions and other symptoms requiring immediate care. A list cannot cover every emergency; severe or rapidly worsening symptoms need urgent assessment.

Serious symptoms: contact a clinician immediately

Ongoing significant abdominal pain, especially pain that travels toward the back, with or without vomiting, needs prompt evaluation. It should not be assumed to be ordinary nausea. Repeated vomiting, inability to keep fluids down, marked dizziness or much less urination also deserve immediate clinical advice; severe symptoms may require emergency care.

Report new vision changes promptly. New neck swelling, a lump, persistent hoarseness or trouble swallowing also needs assessment; difficulty breathing is an emergency. Upper-abdominal pain with fever or yellowing of the skin or eyes should not wait for a routine follow-up.

These examples do not diagnose pancreatitis, dehydration, gallbladder disease or another condition. They explain why self-treating an unexplained serious symptom can delay care. If the treating team cannot be reached promptly, use urgent medical services appropriate to the symptom severity.

Common digestive symptoms still deserve follow-up

Milder nausea, constipation, diarrhea or stomach discomfort may be discussed with the prescriber, particularly when symptoms persist or interfere with meals, sleep, work or normal activities. Keep track of when symptoms began and whether they followed a treatment change.

Useful details to report include:

  • The exact product name, the prescribed instructions and when the last dose was taken.
  • When the symptom started, how it has changed and whether there is pain, fever or vomiting.
  • Whether fluids and food stay down and whether urination has changed.
  • Other medicines, supplements and any recent illness.
  • Effects on everyday activities and whether the symptom is recurring.

The treating clinician can decide whether an examination, tests or a treatment change is needed. Do not improvise a dose change, add a remedy or continue an escalation simply because another person had similar symptoms. Follow urgent instructions in your own medication guide.

Have a plan for low blood sugar

Some people also use medicines that can lower blood sugar. Ask the treating clinician how to recognize low glucose and what to do in your particular situation. Do not assume shakiness, sweating, dizziness or confusion is just an expected part of losing weight. Severe confusion, unconsciousness or a seizure needs emergency help.

Review safety before the next change

Ask whom to contact after hours, which symptoms should change the plan and what to do before the next scheduled dose if you are unwell. A written plan is more useful than being told to push through side effects.

If product identity or instructions are unclear, involve the pharmacist or prescriber. The FDA's unapproved GLP-1 safety information describes concerns including dosing errors and product quality. For the broader treatment discussion, read what a medical weight loss consultation should cover.

Your next step

Prepare questions for your next routine review.

Explore Allura’s medical weight-management service and the questions to bring to a routine discussion about monitoring and follow-up.

Follow the urgent-care guidance above for warning signs. This link is for routine enquiries, not urgent medical support.